Results 151 to 160 of about 26,086 (200)

PD-1/TIGIT CD4⁺ T-Cell Signature for Risk Stratification of Post-Weaning Mortality in Venoarterial Extracorporeal Membrane Oxygenation Patients. [PDF]

J Inflamm Res
Wang Z, Hao X, Han J, Li C, Wang L, Chen J, Chen J, Cao Y, Jiang Y, Ji H, Li J, Zhang J, Wang H, Hua M, Zeng H, Hou X, Chen C.   +16 more
europepmc   +1 more source

The co-inhibitory receptor TIGIT promotes tissue-protective functions in T cells

The co-inhibitory receptor TIGIT suppresses excessive immune responses in autoimmune conditions while also restraining antitumor immunity. In viral infections, TIGIT alone does not affect viral control but has been shown to limit tissue pathology ...
Yermanos, Alexander, Agrafiotis, Andreas, Panetti, Camilla, Kallies, Axel, King, Carolyn G., Patikas, Nikolaos, Infection & Immunity, Daetwyler, Rahel, Joller, Nicole, Hemberg, Martin, Vasanthakumar, Ajithkumar, Tang, Adelynn, Iannacone, Matteo, CTI, Wen, Lifen, Moncsek, Anja, Andreata, Francesco, CTI Yermanos, Fumagalli, Valeria, De Lima, Jean   +19 more
core  

Dual TIGIT and PD-1 blockade in immunotherapy-refractory hepatocellular carcinoma: a signal beyond resistance? [PDF]

Hepatobiliary Surg Nutr
Franzè MS, Amaddeo G.
europepmc   +1 more source

P184 | PROINFLAMMATORY BONE MARROW NICHES AND NEUTROPHIL ACTIVATION ARE ASSOCIATED WITH TIGIT EXPRESSION IN MULTIPLE MYELOMA

Multiple Myeloma (MM) is the second most frequent hematologic malignancy in adults in the Western world. The bone marrow microenvironment plays a critical role in MM progression by supporting malignant plasma cell (PC) survival, immune evasion, and ...
F. Arciprete, B. Mecorio, O. Annibali, M. Tafuri, M. Zingariello, A. Bianchi, V. Velardi, M. De Cecca, V. Tomarchio, l Rigacci, A. Crescenzi   +10 more
core  

Intercellular Transfer of CD155 Mediated by Melanoma Extracellular Vesicles Downregulates DNAM-1 Expression on NK Cells. [PDF]

Int J Mol Sci
Wu LY, Lima LG, Ham S, Lim M, Park SH, Su Y, Li X, Chai EPZ, Braun M, Choi YS, Bald T, Möller A.   +11 more
europepmc   +1 more source

Longitudinal Flow Cytometric Profiling of CAR-T and Endogenous T Cells Following CD19 CAR-T Therapy. [PDF]

Cancers (Basel)
Jee S, Kang T, Bae H, Kang T, Jung J, Kim Y, Kim M, Yoo JW, Min GJ, Jekarl DW, Lee JM.   +10 more
europepmc   +1 more source

Enzyme replacement therapy (ERT) combined with transient low-dose methotrexate (TLD-MTX) results in age- and disease-dependent immune profile changes in Infantile- vs. late-onset Pompe disease patients. [PDF]

Front Immunol
Amirifar P, Desai AK, Jung SH, Young SP, Smith PB, Lu C, Abar B, Kishnani PS, Burt TD.   +8 more
europepmc   +1 more source

HCV-Specific T-Cell Recovery After a Year of SVR Following DAA Therapy. [PDF]

J Med Virol
Pozniak T, Sharaf S, Gross C, Ebah E, Khanam A, Cover A, Davis A, Kottilil S, Mathur P, Ghosh A.   +9 more
europepmc   +1 more source